🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

9717+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 9717 recruiting trials

Phase 2RecruitingNCT07222579

Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

👨‍⚕️ Ashkan Emadi, MD, WVU Cancer Institute📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07356245

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

👨‍⚕️ Jonathan Brammer, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Feb 2026View details ↗
Phase 1RecruitingNCT07403097

Study of CD19 CAR-T Therapy for Refractory SLE

🏥 Chongqing Precision Biotech Co., Ltd📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07419373

ARN-75039 Lassa Fever Treatment in West Africa

👨‍⚕️ Ken McCormack, PhD, Arisan Therapeutics, Inc.📍 4 sites📅 Started Feb 2026View details ↗
RecruitingNCT07131293

European Registry Study on Lymphatic Interventions

👨‍⚕️ Vibeke E Hjortdal, Professor, Rigshospitalet, Denmark📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07457138

Lombard Cohort of Brain Health Services

👨‍⚕️ Carlo Ferrarese, MD, PhD, University of Milano Bicocca📍 5 sites📅 Started Feb 2026View details ↗
Phase 1RecruitingNCT07102394

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

👨‍⚕️ Carlos Romo, MD, Johns Hopkins University📍 1 site📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT07407803

Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 29 sites📅 Started Feb 2026View details ↗
Phase 4RecruitingNCT07280468

Endotype DIrected Treatment for OSA in Down Syndrome

👨‍⚕️ Daniel Combs, MD, University of Arizona📍 4 sites📅 Started Feb 2026View details ↗
RecruitingNCT07449793

Biochemical Response and Clinical Outcomes in Patients With PBC

👨‍⚕️ Xiong Ma, MD, PhD, RenJi Hospital📍 1 site📅 Started Feb 2026View details ↗
EARLY_Phase 1RecruitingNCT07389499

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases

🏥 Grit Biotechnology📍 1 site📅 Started Jan 2026View details ↗
Phase 2, PHASE3RecruitingNCT07080385

Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

👨‍⚕️ Calcilytix Medical Director, Calcilytix Therapeutics, Inc., a BridgeBio company📍 5 sites📅 Started Jan 2026View details ↗
NARecruitingNCT07307664

Increasing Germline Genetic Testing for Patients With Cancer

👨‍⚕️ Josh F Peterson, MD, MPH, Vanderbilt University Medical Center📍 10 sites📅 Started Jan 2026View details ↗
NARecruitingNCT07374289

On Scene ECPR in Ostrava

👨‍⚕️ Filip Burša, MD, PhD, EDEC, University Hospital Ostrava📍 2 sites📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT07397832

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

👨‍⚕️ Huilai Zhang, Tianjin Medical University Cancer Insititute & Hospital📍 1 site📅 Started Jan 2026View details ↗
NARecruitingNCT07187388

Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.

🏥 Nova Southeastern University📍 1 site📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT06594393

A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

🏥 Xinnate AB📍 6 sites📅 Started Jan 2026View details ↗
Phase 3RecruitingNCT07363720

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

👨‍⚕️ Study Director, Takeda📍 7 sites📅 Started Jan 2026View details ↗
Enrolling by InvitationNCT07474051

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

🏥 AvenCell Therapeutics, Inc.📍 5 sites📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT06878274

Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC

🏥 Centre hospitalier de l'Université de Montréal (CHUM)📍 1 site📅 Started Jan 2026View details ↗
← PreviousPage 18 of 486Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →